These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


106 related items for PubMed ID: 445948

  • 21. Comparison of the acute effects of acebutolol and propranolol on blood pressure, heart rate and hormonal changes during graded treadmill exercise in patients with essential hypertension.
    Matsuura H, Masaoka S, Kanazawa I, Murano S, Tsuchioka Y, Kajiyama G.
    Jpn J Med; 1989; 28(1):8-15. PubMed ID: 2657144
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Experimental analysis of the cardiovascular effects of acebutolol, a drug with beta-adrenolytic activity].
    Marmo E, Rossi F, Lampa E, Chieppa S, Apolito A, Del Vecchio F.
    Arch Sci Med (Torino); 1978; 135(1):57-78. PubMed ID: 25058
    [Abstract] [Full Text] [Related]

  • 24. [Editorial: Importance of cardioselectivity and sympaticomimetric potential of beta-blockers (author's transl)].
    Dubach UC.
    Schweiz Rundsch Med Prax; 1975 Sep 30; 64(39):1239-41. PubMed ID: 241073
    [No Abstract] [Full Text] [Related]

  • 25. [Comparison of the pA2 of various beta blocking agents].
    Spach MO, Miesch F, Schwartz J.
    Nouv Presse Med; 1975 Dec 31; 4(46 Suppl):3221-2. PubMed ID: 3766
    [Abstract] [Full Text] [Related]

  • 26. Effects of beta-adrenergic blocking drugs in hypertensive rats.
    Sukamoto T, Shiono K, Watanabe TX, Sokabe H.
    J Pharmacobiodyn; 1980 Jan 31; 3(1):1-10. PubMed ID: 6110712
    [Abstract] [Full Text] [Related]

  • 27. Hemodynamic characterization of a new beta-receptor blocker: mepindolol at rest, during ergometer exercise and in the isoproterenol study in comparison with practolol and pindolol.
    Boneli J.
    Int J Clin Pharmacol Biopharm; 1977 Jul 31; 15(7):325-31. PubMed ID: 19363
    [No Abstract] [Full Text] [Related]

  • 28. The effects of oral acebutolol and propranolol on forearm blood flow in hypertensive patients.
    Ireland MA, Littler WA.
    Br J Clin Pharmacol; 1981 Sep 31; 12(3):363-8. PubMed ID: 7295466
    [Abstract] [Full Text] [Related]

  • 29. Comparison of the beta 1 and beta 2 adrenoceptor blocking properties of acebutolol and propranolol.
    Whitsett TL, Levin DC, Manion CV.
    Chest; 1982 Dec 31; 82(6):668-73. PubMed ID: 6128186
    [Abstract] [Full Text] [Related]

  • 30. [Differences in hemodynamic effects of the cardioselective beta-adrenoblocker acebutolol and non-selective beta-adrenoblocker propranolol in long-term antihypertensive therapy].
    Metelitsa VI, Duda SG, Ostrovskaia TP, Malysheva NV, Lerman OV, Shastun RS, Manoshkina EM, Piotrovskiĭ VK, Rumiantsev DO, Belolipetskaia VG.
    Kardiologiia; 1993 Dec 31; 33(4):32-8. PubMed ID: 7933789
    [Abstract] [Full Text] [Related]

  • 31. Comparative beta-blocking potencies of acebutolol and propranolol relative to plasma drug levels.
    Collett JT, Hendrickson JA, Chew CY, Shah PM, Laddu AR, Singh BN.
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov 31; 19(11):473-8. PubMed ID: 6117519
    [Abstract] [Full Text] [Related]

  • 32. Renal effects of propranolol, practolol and butoxamine in pentobarbital-anesthetized rats.
    Shibouta Y, Nishikawa K, Kikuchi S, Shimamoto K.
    Eur J Pharmacol; 1979 Jan 01; 53(2):201-8. PubMed ID: 759198
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Influence of propranolol and acebutolol on isoprenaline-induced changes in heart rate and peripheral blood flow in man.
    Mougeot G, Hugues FC, Julien D, Marche J.
    Arch Int Pharmacodyn Ther; 1981 May 01; 251(1):116-25. PubMed ID: 7259364
    [Abstract] [Full Text] [Related]

  • 35. New approach to assessment of cardioselectivity of beta-blocking drugs.
    Kumana CR, Marlin GE, Kaye CM, Smith DM.
    Br Med J; 1974 Nov 23; 4(5942):444-7. PubMed ID: 4425917
    [Abstract] [Full Text] [Related]

  • 36. [Hemodynamic effects of some beta-adrenergic blocking agents in conscious spontaneously hypertensive rats (author's transl)].
    Matsunaga K, Ueda M.
    Nihon Yakurigaku Zasshi; 1981 Jun 23; 77(6):597-604. PubMed ID: 6116655
    [Abstract] [Full Text] [Related]

  • 37. Effect of acebutolol, a new beta-receptor antagonist on heart rate and rate-pressure product in normal subjects.
    Sharma PL.
    Int J Clin Pharmacol Biopharm; 1976 Dec 23; 14(4):290-7. PubMed ID: 1002366
    [Abstract] [Full Text] [Related]

  • 38. Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?
    Taylor SH, Silke B, Lee PS.
    N Engl J Med; 1982 Mar 18; 306(11):631-5. PubMed ID: 6120457
    [Abstract] [Full Text] [Related]

  • 39. The effects of prolonged beta-adrenoceptor blockade on heart weight and cardiac intracellular potentials in rabbits.
    Williams EM, Raine AE, Cabrera AA, Whyte JM.
    Cardiovasc Res; 1975 Sep 18; 9(5):579-92. PubMed ID: 1201566
    [Abstract] [Full Text] [Related]

  • 40. [Comparative studies on practolol, pindolol and propranolol effect on hemodynamics and contractility of left ventricle in coronary disease patients].
    Limbourg P, Just H, Lang KF.
    Verh Dtsch Ges Inn Med; 1973 Sep 18; 79():1006-9. PubMed ID: 4790080
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.